The Tale of a Double-Edged Sword

The Tale of a Double-Edged Sword

Bibliographic Details
Main Authors:	Giselle A. Suero-Abreu, MD, PhD, Sherry-Ann Brown, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	JACC: Case Reports
Subjects:	cardiac metastases cardio-oncology cardiovascular imaging immune checkpoint inhibitors
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666084919300282

Similar Items

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
by: Frederik Uttenthal Larsen, MD, et al.
Published: (2019-06-01)

Tales of the Unexpected
by: Charlotte Manisty, MD, PhD, et al.
Published: (2019-10-01)

Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer
by: Angel T. Chan, et al.
Published: (2017-10-01)

Cardiovascular Effects of CAR T Cell Therapy
by: Bénédicte Lefebvre, MD, et al.
Published: (2020-06-01)

A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
by: Jessica Castrillon Lal, et al.
Published: (2021-05-01)

Working Together to Advance Cardio-Oncology in China
by: Yunlong Xia, MD, PhD, et al.
Published: (2020-03-01)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020-04-01)

Cardio-Oncology in China
by: Yuhui Zhang, MD, et al.
Published: (2020-03-01)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
by: Nikhil Agrawal, et al.
Published: (2019-03-01)

Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center
by: Nida Waheed, et al.
Published: (2021-03-01)

The Establishment of the Nordic Cardio-Oncology Society
by: Agneta Månsson Broberg, MD, PhD, et al.
Published: (2020-06-01)

Where the Seed of Healing Is Planted
by: Patricia A. Wetzel, BS, et al.
Published: (2019-12-01)

Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment
by: Kekoa Taparra, MD, PhD, et al.
Published: (2020-09-01)

Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT
by: Daniel Finke, et al.
Published: (2021-02-01)

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
by: Robert S. Zhang, et al.
Published: (2021-03-01)

Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity
by: Angel T. Chan, et al.
Published: (2021-04-01)

Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms
by: Rishi Rikhi, et al.
Published: (2021-08-01)

Cardio-Oncology in Argentina
by: Andrés J. Daniele, MD, et al.
Published: (2020-06-01)

Birth and Maturation of Cardio-Oncology
by: Deepak L. Bhatt, MD, MPH
Published: (2019-09-01)

Preventive Cardio-Oncology: The Time Has Come
by: Sherry-Ann Brown
Published: (2020-01-01)

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2018-10-01)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
by: Anthony F. Yu, MD, et al.
Published: (2020-06-01)

An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors
by: Roberta Esposito, et al.
Published: (2021-05-01)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy
by: Iwan Harries, MBBCh, et al.
Published: (2020-06-01)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors∗
by: Dorothy M. Gujral, PhD, et al.
Published: (2020-02-01)

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
by: Michał Wilk, et al.
Published: (2021-04-01)

Cardiac Tamponade as the First Manifestation of Erdheim-Chester Disease
by: Isabela B.S. da S. Costa, MD, et al.
Published: (2020-06-01)

21st Century Cardio-Oncology
by: Calvin Chen Sheng, MD, et al.
Published: (2016-08-01)

Cardiovascular Prevention in Individuals at High Risk of Developing Cancer
by: Ohad Oren, MD, et al.
Published: (2020-09-01)

Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors
by: Ming Yuan, et al.
Published: (2021-10-01)

Cardio-Oncology – A new subspecialty with collaboration at its heart
by: Arjun K. Ghosh, et al.
Published: (2017-07-01)

Osimertinib-Induced Cardiomyopathy
by: Shruti R. Patel, MD, et al.
Published: (2020-04-01)

Cardio-Oncology in Israel
by: Zaza Iakobishvili, MD, PhD, et al.
Published: (2019-12-01)

A new classification of cardio-oncology syndromes
by: Rudolf A. de Boer, et al.
Published: (2021-06-01)

Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
by: Nicola Tumino, et al.
Published: (2020-01-01)

Primer on Biomarker Discovery in Cardio-Oncology
by: June-Wha Rhee, MD, et al.
Published: (2020-09-01)

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
by: Koichi Egashira, et al.
Published: (2021-06-01)

Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity
by: Richard K. Cheng, MD, MSc, et al.
Published: (2019-12-01)

Cardio-Oncology: Success Breeds New Challenges, Opportunities
by: Charles A. Bomzer, et al.
Published: (2014-08-01)

Editorial: Cardio-Oncology: From Bench to Bedside
by: Jun-ichi Abe, et al.
Published: (2019-04-01)